Qianhai Health Holdings Limited

Equities

911

KYG7307F1046

Drug Retailers

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
0.04 HKD -4.76% Intraday chart for Qianhai Health Holdings Limited +21.21% +8.11%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Qianhai Health's Loss Shrinks in 2023 MT
Qianhai Health Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Qianhai Health Holdings Limited Provides Group Earnings Guidance for the Year Ended 31 December 2023 CI
Qianhai Health Proposes Cooperation With LiZhiXi Health Management for Product Sales MT
Qianhai Health Company Limited Signs Letter of Intent of Strategic Cooperation with Shenzhen LiZhiXi Health Management Limited CI
Qianhai Health Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Qianhai Health Flags HK$110 Million Loss for H1 MT
Qianhai Health Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Qianhai Health Sees Wider 2022 Loss; Shares Plummet 24% MT
Qianhai Health Holdings Limited Provides Group Earnings Guidance for the Year Ended 31 December 2022 CI
Qianhai Health Swings to Profit in January-July Results MT
Qianhai Health Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Qianhai Health Holdings Limited Provides Financial Guidance for the Six Months Ended 30 June 2022 CI
Qianhai Health Holdings Company Limited Announces Board and Committee Changes CI
Qianhai Health Holdings Limited Announces Director Changes CI
Qianhai Health Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Qianhai Health Holdings Limited Appoints Leung Chun Tung S an Independent Non-Executive Director and A Member of the Audit Committee of the Company CI
Qianhai Health Holdings Limited Announces Resignation of Wu Wai Leung Danny as Independent Non-Executive Director and Change in Composition of Board Committees CI
Qianhai Health Holdings Limited Announces Director Appointments CI
Qianhai Health Holdings Limited Reports Condensed Unaudited Consolidated Earnings Results for the Six Months Ended 30 June 2021 CI
Qianhai Health Holdings Limited Revises Group Earnings Guidance for the 2021 Interim Period CI
Qianhai Health Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021 CI
Qianhai Health : Sign Strategic Cooperation Deal with Shenzhen Murong Health Management MT
Qianhai Health Holdings Limited Enters into Strategic Cooperation Agreement with Shenzhen Murong Health Management Limited CI
Qianhai Health Holdings Limited Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2020 CI
Chart Qianhai Health Holdings Limited
More charts
Qianhai Health Holdings Limited is an investment holding company principally engaged in the sourcing and wholesaling of American Ginseng. Along with subsidiaries, the Company operates its business through four segments. The Cultivated Ginseng segment is engaged in the purchasing and sale of cultivated American ginseng. The Wild Ginseng segment is engaged in the purchasing and sale of wild ginseng from the United States. The Ginseng Wine segment is engaged in the manufacturing and sale of ginseng wine. Its wine products include American wild ginseng brandy and American wild ginseng white spirit. The Others segment is engaged in the trading of other products, including dried cordyceps, dried cubilose, dried seafood and skin care products, among others.
More about the company
  1. Stock Market
  2. Equities
  3. 911 Stock
  4. News Qianhai Health Holdings Limited
  5. Qianhai Health Swings to Profit in January-July Results